Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2025-12-27 @ 7:47 PM
Study NCT ID:
NCT04371666
Status:
TERMINATED
Last Update Posted:
2024-03-12
First Post:
2020-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Sponsor:
FibroGen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-17
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-29
First Submit QC Date:
None
Study First Post Date:
2020-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-02-13
Results First Submit QC Date:
None
Results First Post Date:
2024-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-13
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL